Showing results (91-100 of 121) with videos related to
Sort By:
Pageof 13
International Journal of Cardiology|September 21, 2015
AHEAD score--Long-term risk classification in acute heart failureJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.ESC Heart Failure|February 21, 2017
Worse prognosis of real-world patients with acute heart failure from the Czech AHEAD registry in comparison to patients from the RELAX-AHF trialJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.Annals of Intensive Care|January 5, 2017
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shockHeli Tolppanen, Mercedes Rivas-Lasarte, Johan Lassus, et al.Lancet (London, England)|September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trialAndreas Goette, Jose L Merino, Michael D Ezekowitz, et al.Journal of Hypertension|October 17, 2017
Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IVRoland E Schmieder, Christian Ott, Stefan W Toennes, et al.Journal of the American College of Cardiology|December 10, 2013
Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradoxRavi Shah, Etienne Gayat, James L Januzzi, et al.European Heart Journal|December 8, 2019
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54Remo H M Furtado, Jose C Nicolau, Giulia Magnani, et al.European Journal of Heart Failure|October 1, 2015
Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohortAntonio Teixeira, Jiri Parenica, Jin Joo Park, et al.European Journal of Heart Failure|August 30, 2017
Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched studyEtienne Gayat, Mattia Arrigo, Simona Littnerova, et al.The New England Journal of Medicine|January 22, 2025
Abelacimab versus Rivaroxaban in Patients with Atrial FibrillationChristian T Ruff, Siddharth M Patel, Robert P Giugliano, et al.Pageof 13